Rituximab May Hold Promise in Treating Pediatric Burkitt Lymphoma - MY HEALTH TODAY

Breaking

Home Top Ad

Responsive Ads Here

Post Top Ad

Responsive Ads Here

Thursday, June 4, 2020

Rituximab May Hold Promise in Treating Pediatric Burkitt Lymphoma

Results of the phase III Inter-B-NHL-ritux 2010 clinical trial shows the effectiveness of Rituximab in improving the survival rate among kids with non-Hogkin lymphoma.


from Medindia Health News https://ift.tt/3gUhhY4
via

No comments:

Post a Comment

Post Bottom Ad

Responsive Ads Here

Pages